Silencing of endo-exonuclease expression sensitizes mouse B16F10 melanoma cells to DNA damaging agents Sibgat A. ChoudhuryPaul KaulerTerry Y-K Chow PRECLINICAL STUDIES 11 May 2007 Pages: 399 - 410
Modulation of tumor radiation response with G3139, a bcl-2 antisense oligonucleotide Nicole WiedenmannMasashi KotoKathryn A. Mason PRECLINICAL STUDIES 11 May 2007 Pages: 411 - 416
In vitro chemosensitivity of freshly explanted tumor cells to pemetrexed is correlated with target gene expression Axel-Rainer HanauskeUlrike EismannClet Niyikiza PRECLINICAL STUDIES 30 May 2007 Pages: 417 - 423
Dimethylamino-functionalised and N-heteroaryl-substituted titanocene anticancer drugs: synthesis and cytotoxicity studies Thomas HickeyJames ClaffeyMatthias Tacke PRECLINICAL STUDIES 22 May 2007 Pages: 425 - 433
Different cell cycle modulation following treatment of human ovarian carcinoma cells with a new platinum(IV) complex vs cisplatin Viktor HorváthKarel SoučekAlois Kozubík PRECLINICAL STUDIES 23 May 2007 Pages: 435 - 443
Phase I dose escalation and pharmacokinetic study of AZD2171, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinase, in patients with hormone refractory prostate cancer (HRPC) Charles J. RyanWalter M. StadlerEric J. Small PHASE I STUDIES 26 April 2007 Pages: 445 - 451
A phase I and pharmacokinetic study of irofulven and capecitabine administered every 2 weeks in patients with advanced solid tumors Jérôme AlexandreCarmen KahattEsteban Cvitkovic PHASE I STUDIES 13 July 2007 Pages: 453 - 462
Docetaxel–ifosfamide combination in patients with HER2-non-overexpressing advanced breast cancer failing prior anthracyclines Christos KosmasNicolas TsavarisAthanasios Karabelis PHASE II STUDIES 17 March 2007 Pages: 463 - 470
Phase II study of Triapine® in patients with metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada Clinical Trials Group (NCIC IND.161) Jennifer J. KnoxSebastien J. HotteElizabeth A. Eisenhauer PHASE II STUDIES 28 March 2007 Pages: 471 - 477
The efficacy of hybrid chemotherapy with intravenous oxaliplatin and folinic acid and intra-hepatic infusion of 5-fluorouracil in patients with colorectal liver metastases: a phase II study Carlo CarnaghiArmando SantoroIsabella Garassino PHASE II STUDIES 11 May 2007 Pages: 479 - 485
Phase II Trial of ixabepilone in patients with cisplatin-refractory germ cell tumors Darren R. FeldmanG. Varuni KondaguntaRobert J. Motzer PHASE II STUDIES 23 May 2007 Pages: 487 - 490
Effects of dutasteride on the expression of genes related to androgen metabolism and related pathway in human prostate cancer cell lines Michela BiancolellaAlessandra ValentiniGiuseppe Novelli SHORT REPORT 18 July 2007 Pages: 491 - 497
Amrubicin for non-small-cell lung cancer and small-cell lung cancer Takayasu KurataIsamu OkamotoMasahiro Fukuoka Review 13 July 2007 Pages: 499 - 504